MedTrace Logo

Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment

NCT06730139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-12-12

No results posted yet for this study

Summary

Oral Health-Related Quality of Life in Head and Neck Cancer Patients

Problem Statement:

Head and Neck Cancer (HNC) is a significant global health issue, and its incidence is rising. While treatment options have improved, they often lead to severe oral complications, impacting patients' quality of life.

Research Gap:

Limited research exists on oral health-related quality of life (OHRQoL) among HNC patients in Egypt, particularly focusing on the impact of oral clinical parameters and treatment-related factors.

Research Objective:

To assess the OHRQoL of HNC patients who have completed treatment within the past 12 months and to identify factors associated with impaired OHRQoL.

Methodology:

This study will employ a comprehensive approach to evaluate OHRQoL, considering:

Oral Clinical Parameters: Oral hygiene status, oral mucositis, and other oral health indicators.

Sociodemographic Factors: Age, gender, education, occupation, and socioeconomic status.

Treatment-Related Variables: Type of treatment (surgery, radiation therapy, chemotherapy), treatment duration, and dose intensity.

Expected Outcomes:

The findings of this study will:

Quantify the impact of HNC treatment on OHRQoL. Identify key factors associated with impaired OHRQoL. Highlight the importance of standardized oral care for HNC patients. Provide evidence-based recommendations for improving oral health support and enhancing the overall quality of life for HNC survivors.

By addressing the oral health needs of HNC patients, this research aims to improve their quality of life and contribute to better long-term outcomes.

Conditions

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-20
Primary Completion
2024-08-20
Completion
2024-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06730139 on ClinicalTrials.gov